Healthcare Triangle, Inc. (HCTI)
NASDAQ: HCTI · Real-Time Price · USD
2.420
+0.010 (0.41%)
At close: May 27, 2026, 4:00 PM EDT
2.350
-0.070 (-2.88%)
After-hours: May 27, 2026, 5:09 PM EDT

Healthcare Triangle Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-15.67-9.48-5.97-8.69-14.36-5.95
Depreciation & Amortization
0.810.710.891.572.941.42
Stock-Based Compensation
0.840.840.110.270.381.2
Other Adjustments
2.760.11.21.71.930.17
Change in Receivables
-1.66-0.912.322.273.59-3.28
Changes in Accounts Payable
-0.28-1.490.590.48-0.39-2.48
Changes in Accrued Expenses
-1.020.27-0.53-0.521.270.08
Changes in Other Operating Activities
-3.63-6.560.310.76-0.711.72
Operating Cash Flow
-23.38-16.52-1.08-2.15-5.35-7.11
Capital Expenditures
-0---0.01-0.04-0.08
Purchases of Intangible Assets
-0.22-1.5---1.09-3.05
Payments for Business Acquisitions
-6-----4.5
Other Investing Activities
--0.25----
Investing Cash Flow
-6.02-1.75--0.01-1.13-7.63
Short-Term Debt Issued
0.559.41-1.091.560.48-
Short-Term Debt Repaid
-0-----
Net Short-Term Debt Issued (Repaid)
0.559.41-1.091.560.48-
Long-Term Debt Issued
-----1.07
Net Long-Term Debt Issued (Repaid)
-----1.07
Issuance of Common Stock
25.917.030.960.55.9214.22
Repurchase of Common Stock
-----0.14-
Net Common Stock Issued (Repurchased)
25.917.030.960.55.7814.22
Other Financing Activities
-0.79-0.57---0.19-0.18
Financing Cash Flow
35.3425.88-0.132.066.0615.11
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.1-----
Net Cash Flow
-3.317.61-1.21-0.11-0.430.37
Free Cash Flow
-23.39-16.52-1.08-2.16-5.39-7.19
FCF Margin
-116.69%-118.95%-9.24%-6.51%-11.75%-20.39%
Free Cash Flow Per Share
-79.24-267.05-3062.32-7732.50-21784.60-29047.40
Levered Free Cash Flow
-17.55-7.14-5.79-4.85-10.82-4.21
Unlevered Free Cash Flow
-36.15-16.86-3.49-5.45-13.85-4.71
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q